Australians use unapproved Ozempic for weight loss amid global demand and celebrity endorsements, prompting regulatory action.
Australians are accessing the diabetes drug Ozempic, which is not approved for weight loss in the country, due to high global demand and celebrity endorsements. While only approved for diabetes treatment in Australia, Ozempic is marketed as Wegovy for weight loss overseas. Faced with limited access and the practice known as "off-label" use, Australia's Therapeutic Goods Administration plans to clamp down on the distribution of Ozempic for weight loss purposes.
April 03, 2024
5 Articles